Published in BMC Ophthalmol on June 04, 2004
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Autoimmune retinopathy: a review and summary. Semin Immunopathol (2008) 2.16
The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol (2008) 1.83
Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev (2009) 1.68
Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol (2009) 1.20
The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol (2007) 1.19
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Autoimmune retinopathy. Am J Ophthalmol (2013) 1.08
Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. J Autoimmun (2009) 1.03
Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes (2008) 1.02
Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy. J Ophthalmic Inflamm Infect (2011) 1.00
Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies. Exp Mol Pathol (2009) 0.93
Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 0.93
Hyperautofluorescent ring in autoimmune retinopathy. Retina (2012) 0.91
Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease? Autoimmune Dis (2014) 0.91
Paraneoplastic syndromes in patients with primary head and neck cancer. Eur Arch Otorhinolaryngol (2007) 0.87
Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol (2012) 0.87
Significance of Anti-retinal Autoantibodies in Cancer-associated Retinopathy with Gynecological Cancers. J Clin Exp Ophthalmol (2013) 0.86
Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens. Mol Vis (2008) 0.85
Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy. J Ophthalmic Inflamm Infect (2012) 0.84
Retinal imaging with en face and cross-sectional optical coherence tomography delineates outer retinal changes in cancer-associated retinopathy secondary to Merkel cell carcinoma. J Ophthalmic Inflamm Infect (2015) 0.82
Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy. BMC Ophthalmol (2013) 0.82
Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration. BMC Ophthalmol (2014) 0.82
Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats. J Neuroimmunol (2012) 0.82
A denileukin diftitox (Ontak) associated retinopathy? Br J Ophthalmol (2006) 0.81
Anti-γ-enolase autoimmune retinopathy manifesting in early childhood. Arch Ophthalmol (2010) 0.79
Small cell lung cancer and progressive retinopathy. BMJ Case Rep (2014) 0.79
Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer. Invest Ophthalmol Vis Sci (2015) 0.79
Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss. Doc Ophthalmol (2012) 0.79
Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol (2016) 0.78
Cancer-associated retinopathy as the leading symptom in colon cancer. Clin Case Rep (2015) 0.78
Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy. Clin Ophthalmol (2017) 0.77
Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration? Autoimmun Rev (2017) 0.76
Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy. PLoS One (2016) 0.75
Autoimmune retinopathy: A case report from India. Oman J Ophthalmol (2017) 0.75
A unique case of autoimmune retinopathy associated with anti-alpha-enolase antibodies. Case Rep Ophthalmol Med (2011) 0.75
Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders. Front Immunol (2017) 0.75
Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea. Yonsei Med J (2016) 0.75
The enigma of autoimmune retinopathy. Int Ophthalmol Clin (2015) 0.75
GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy. Transl Vis Sci Technol (2016) 0.75
Autoimmune retinopathy associated with systemic lupus erythematosus: A diagnostic dilemma. Taiwan J Ophthalmol (2017) 0.75
Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy. Orphanet J Rare Dis (2017) 0.75
The dilemma of the late-onset "dystrophy". Doc Ophthalmol (2007) 0.75
B Cell Anomalies in Autoimmune Retinopathy (AIR). Invest Ophthalmol Vis Sci (2017) 0.75
Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol (1998) 2.89
Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol (2000) 2.65
Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med (1989) 2.02
Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci (1993) 1.62
Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol (2001) 1.59
The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol (1996) 1.54
Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci (1997) 1.30
Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci (2000) 1.29
Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol (1983) 1.29
Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun (1998) 1.28
The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci (2000) 1.26
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev (2003) 1.24
Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol (1997) 1.22
Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun (1998) 1.22
Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci (1999) 1.04
Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol (2002) 1.02
Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci (2000) 1.02
Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy. Arch Ophthalmol (1998) 0.96
An unusual type of cancer-associated retinopathy in a patient with ovarian cancer. Korean J Ophthalmol (1999) 0.96
Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol (2001) 0.93
Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy. Clin Exp Immunol (2002) 0.93
Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol (1997) 0.92
Müller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci (1998) 0.91
Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci (1999) 0.90
The 22-kDa antigen in optic nerve and retinal diseases. J Neuroophthalmol (1999) 0.89
Passive administration of antibody against retinal S-antigen induces electroretinographic supernormality. Invest Ophthalmol Vis Sci (1992) 0.88
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy. Lung Cancer (2003) 0.88
Age-related macular degeneration--a genome scan in extended families. Am J Hum Genet (2003) 2.99
Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet (2002) 2.94
Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet (2003) 2.72
Long-term effect of gene therapy on Leber's congenital amaurosis. N Engl J Med (2015) 2.68
CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet (2005) 2.37
Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol (2011) 2.27
Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am J Hum Genet (2005) 2.25
Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology (2012) 2.21
Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet (2004) 2.13
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest (2008) 1.86
Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. Am J Hum Genet (2010) 1.72
Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children. Genet Med (2010) 1.56
Photoreceptor calcium channels: insight from night blindness. Vis Neurosci (2005) 1.51
Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol (2004) 1.48
Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci (2012) 1.47
The 'dark' side of sedation: 12 years of office-based pediatric deep sedation for electroretinography in the dark. Paediatr Anaesth (2011) 1.45
Localization of nyctalopin in the mammalian retina. Eur J Neurosci (2006) 1.44
Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. Am J Ophthalmol (2013) 1.34
Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis. Nat Genet (2012) 1.31
The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered (2007) 1.30
Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa. Ophthalmology (2010) 1.30
Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum Mol Genet (2013) 1.27
Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J Hum Genet (2003) 1.27
Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab (2005) 1.23
Retinal effects of 6 months of daily use of tadalafil or sildenafil. Arch Ophthalmol (2009) 1.20
The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol (2007) 1.19
Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Invest Ophthalmol Vis Sci (2008) 1.16
Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum Mutat (2012) 1.15
Molecular testing for hereditary retinal disease as part of clinical care. Arch Ophthalmol (2007) 1.12
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Mol Ther (2011) 1.07
Discordant phenotypes in fraternal twins having an identical mutation in exon ORF15 of the RPGR gene. Arch Ophthalmol (2008) 1.06
Contrasting phenotypes in three patients with novel mutations in mitochondrial tRNA genes. Mol Genet Metab (2004) 1.04
High-resolution optical coherence tomography shows new aspects of Bietti crystalline retinopathy. Retina (2010) 1.04
Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). Am J Ophthalmol (2005) 1.03
Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One (2007) 1.02
Clinical diagnoses that overlap with choroideremia. Can J Ophthalmol (2003) 1.00
Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol (2003) 0.99
Autosomal recessive retinitis pigmentosa caused by mutations in the MAK gene. Invest Ophthalmol Vis Sci (2011) 0.98
Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23. Am J Ophthalmol (2003) 0.98
Choroideremia: analysis of the retina from a female symptomatic carrier. Ophthalmic Genet (2008) 0.97
Acute macular outer retinopathy (AMOR): a reappraisal of acute macular neuroretinopathy using multimodality diagnostic testing. Arch Ophthalmol (2011) 0.96
Outcome measures and their application in clinical trials for retinal degenerative diseases: outline, review, and perspective. Retina (2005) 0.95
Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis. Epilepsy Res (2009) 0.93
Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies. Exp Mol Pathol (2009) 0.93
Novel mutations in the KCNV2 gene in patients with cone dystrophy and a supernormal rod electroretinogram. Ophthalmic Genet (2007) 0.92
Residual electroretinograms in young Leber congenital amaurosis patients with mutations of AIPL1. Invest Ophthalmol Vis Sci (2011) 0.92
HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: review and perspective. Ophthalmic Genet (2005) 0.91
Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy. Arch Ophthalmol (2009) 0.88
Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab (2012) 0.87
The effects of polymorphisms on human gene targeting. Nucleic Acids Res (2013) 0.85
Expanded genome scan in extended families with age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 0.85
Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus. Retina (2004) 0.84
Clinical phenotype as a prognostic factor in Stargardt disease. Retina (2004) 0.84
Isoflurane is an effective alternative to ketamine/xylazine/acepromazine as an anesthetic agent for the mouse electroretinogram. Doc Ophthalmol (2007) 0.84
Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2. Ophthalmic Genet (2008) 0.83
International Federation of Clinical Neurophysiology: recommendations for visual system testing. Clin Neurophysiol (2010) 0.83
Variability in isopter position and fatigue during semi-automated kinetic perimetry. Ophthalmologica (2011) 0.82
Joubert syndrome surviving to adulthood associated with a progressive movement disorder. Mov Disord (2007) 0.82
Conorenal dysplasia: a syndrome of cone-shaped epiphysis, renal disease in childhood, retinitis pigmentosa and abnormality of the proximal femur. Am J Med Genet A (2007) 0.82
Microcephaly with chorioretinopathy in a brother-sister pair: evidence for germ line mosaicism and further delineation of the ocular phenotype. Am J Med Genet A (2007) 0.82
Distal arthrogryposis 5: a dominant syndrome of peripheral contractures and ophthalmoplegia. Am J Med Genet A (2004) 0.82
Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290. JAMA Ophthalmol (2013) 0.81
Stop mutations in exon 6 of the choroideremia gene, CHM, associated with preservation of the electroretinogram. Arch Ophthalmol (2005) 0.81
Electronegative electroretinogram in mucolipidosis IV. Arch Ophthalmol (2002) 0.79
INSIGHTS INTO AUTOSOMAL DOMINANT STARGARDT-LIKE MACULAR DYSTROPHY THROUGH MULTIMODALITY DIAGNOSTIC IMAGING. Retina (2016) 0.79
Mutations in the mitochondrial tRNA Ser(AGY) gene are associated with deafness, retinal degeneration, myopathy and epilepsy. Eur J Hum Genet (2012) 0.76
Author reply: To PMID 22944025. Ophthalmology (2013) 0.75
A unique case of autoimmune retinopathy associated with anti-alpha-enolase antibodies. Case Rep Ophthalmol Med (2011) 0.75
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF CHOROIDAL NEOVASCULARIZATION IN FOUR INHERITED RETINAL DYSTROPHIES. Retina (2016) 0.75
Electroretinographic findings in transplant chorioretinopathy. Clin Ophthalmol (2010) 0.75
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIA. Retina (2017) 0.75